SlideShare a Scribd company logo
“Over the Counter” OTC
Medications
PHAR 437
Abdullah Rabba Ph.D.
• OTC drugs are drugs that have been found to be safe and appropriate
for use without the supervision of a health care professional such as a
physician, and they can be purchased by consumers without a
prescription. -FDA
• Every working day, people come to the community pharmacy for
advice about minor ailments.
• With increasing pressure on doctors’ workload it is likely that the
community pharmacy will be even more widely used as a first port of
call for minor illness.
• Members of the public present to pharmacists and their staff in three
ways:
• Requesting advice about symptoms
• Asking to purchase a named medicine
• Requiring general health advice (e.g. about dietary supplements)
• The pharmacist’s role in responding to symptoms and overseeing the
sale of over the counter (OTC) medicines is substantial and requires a
mix of knowledge and skills in the area of diseases and their
treatment.
Key skills
• Differentiation between minor and more serious symptoms
• Listening skills
• Questioning skills
• Treatment choices based on evidence of effectiveness
• The ability to pass these skills on by acting as a role model for other
pharmacy staff
‘patients’ vs ‘customers’
• refer to the people seeking advice about symptoms as patients.
• In the past the approach has been to see the pharmacist as expert
and the patient as beneficiary of the pharmacist’s information and
advice.
Patients
• They are experts in their own and their children’s health. The patient:
• May have experienced the same or a similar condition in the past
• May have tried different treatments already
• Will have their own ideas about possible causes
• Will have views about different sorts of treatments
• May have preferences for certain treatment approaches
• The pharmacist needs to take this into account in the consultation
with the patient and to enable patients to participate by actively
eliciting their views and preferences.
How to make a consultation more successful from
the patient’s perspective – tips from lay people
• Introduce yourself with unknown patients
• Keep eye contact
• Take your time, don’t show your hurry
• Avoid prejudice – keep an open mind
• Treat patients as human beings and not as a bundle of symptoms
• Pay attention to psychosocial issues
• Take the patient seriously
• Listen – don’t interrupt the patient
• Show compassion; be empathic
• Be honest without being rude
• Avoid jargon, check if the patient understands
• Avoid interruptions
• Offer sources of trusted further information (leaflets, weblinks)
Responding to a request for a named product
• You need to ensure that
• the requested medicine is appropriate, You also need to bear in mind the
• previous knowledge and experience of the purchaser.
• Research shows that the majority of patients do not mind being asked
questions about their OTC medicine purchase.
• exception to this is those who wish to buy a medicine they have used
before and would prefer not to be subjected to the same questions
each time they ask for the product.
• There are two key points here for the pharmacist:
• firstly, it can be helpful to briefly explain why questions are needed, and
• secondly, fewer questions are normally needed where customers request a named
medicine that they have used before.
• A suggested sequence
• Ask whether the person has used the medicine before, and if the answer is
yes, ask if any further information is needed.
• Quickly check on whether other medicines are being taken.
• If the person has not used the medicine before, more questions will be
needed.
• It can be useful to ask how the person came to request this particular
medicine, for example, have they seen an advertisement for it? Has it been
recommended by a friend or family member?
Structuring the consultation
• W – Who is the patient and what are the symptoms?
• H – How long have the symptoms been present?
• A – Action taken?
• M – Medication being taken?
• W: The pharmacist must first establish the identity of the patient: the
• person in the pharmacy might be there on someone else’s behalf.
• H: Duration of symptoms can be an important indicator of whether
referral to the doctor might be required.
• In general, the longer the duration, the more likely is the possibility of
a serious rather than a minor case.
• Most minor conditions are self-limiting and should clear up within a
few days.
• A: Any action taken by the patient should be established, including
the use of any medication to treat the symptoms.
• About one in two patients will have tried at least one remedy before
seeking the pharmacist’s advice.
• If the patient has used one or more apparently appropriate
treatments without improvement, referral to the family doctor may
be the best course of action.
• M: The identity of any medicines taken regularly by the patient is
important for two reasons:
• possible interactions and
• potential adverse reactions.
• The pharmacist needs to know about all the medicines being taken by
the patient
• The community pharmacist has an increasingly important role in detecting
adverse drug reactions, and consideration should be given to the possibility
that the patient’s symptoms might be an adverse effect caused by
medication.
• For example, whether
• gastric symptoms such as indigestion might be due to a (NSAID) or
• a cough might be due to an (ACE) inhibitor being taken by the patient.
• Where the pharmacist suspects an adverse drug reaction to a prescribed
medicine, the pharmacist should discuss with the doctor what actions
should be taken (perhaps including a Yellow Card report to the Commission
on Human Medicines (formerly Committee on Safety of Medicines)
• The second mnemonic, ASMETHOD, was developed by Derek Balon, a
community pharmacist in London:
• A – Age and appearance
• S – Self or someone else
• M – Medication
• E – Extra medicines
• T – Time persisting
• H – History
• O – Other symptoms
• D – Danger symptoms.
• A: Age and appearance
• The appearance of the patient can be a useful indicator of whether a
minor or more serious condition is involved.
• A child who is cheerful and energetic is unlikely to have anything
other than a minor problem, whereas one who is quiet and listless, or
who is fractious, irritable and feverish, might require referral.
• The age of the patient is important because the pharmacist will consider
some symptoms as potentially more serious according to age.
• For example, acute diarrhoea in an otherwise healthy adult could
reasonably be treated by the pharmacist.
• However, such symptoms in a baby could produce dehydration more
quickly; elderly patients are also at a higher risk of becoming dehydrated.
• Oral thrush is common in babies, while less common in older children and
adults; the pharmacist’s decision about whether to treat or refer could
therefore be influenced by age.
• S: Clarification as to who is the patient
• M: Medication regularly taken, on prescription or OTC
• E: Extra medication tried to treat the current symptoms
• T: Time, that is, duration of symptoms
• H: History
• There are two aspects to the term ‘history’ in relation to responding
to symptoms:
• first, the history of the symptom being presented, and second,
• previous medical history. For example, does the patient have diabetes,
hypertension or asthma?
• Questioning about the history of a condition may be useful;
• How and when the problem began,
• how it has progressed and so on.
• If the patient has had the problem before, previous episodes should be asked
about to determine the action taken by the patient and its degree of success.
• O: Other symptoms
• Patients generally tend to complain about the symptoms that concern
them most.
• The pharmacist should always ask whether the patient has noticed any
other symptoms or anything different from usual because, for various
reasons, patients may not volunteer all the importan information.
• Embarrassment may be one such reason, so patients experiencing rectal
bleeding may only mention that they have piles or are constipated.
• The importance or significance of symptoms may not be recognized
by patients, for example, those who have constipation as a side-effect
• from a tricyclic antidepressant will probably not mention their dry
• mouth because they can see no link or connection between the two
problems.
• D: Danger symptoms
• These are the symptoms or combinations of symptoms that should
ring warning bells for pharmacists because immediate referral to the
doctor is required. Blood in the sputum, vomit, urine or faeces would
be examples of such symptoms, as would unexplained weight loss.
• As a general rule, the following indicate a higher risk of a serious condition
and should make the pharmacist consider referring the patient to the
doctor.
• Long duration of symptoms
• Recurring or worsening problems
• Severe pain
• Failed medication (one or more appropriate medicines used already,
without improvement)
• Suspected adverse drug reactions (to prescription or OTC medicine)
• Danger symptoms
Injuries
• The list below provides general guidance on when a person might
need to immediately go to A&E.
• There has been a serious head injury with heavy bleeding.
• The person is, or has been, unconscious.
• There is a suspected broken bone or dislocation.
• The person is experiencing severe chest pain or is having trouble
breathing.
• The person is experiencing severe stomach ache that cannot be
treated by OTC remedies.
• There is severe bleeding from any part of the body.
Privacy in the pharmacy
• The vast majority of community pharmacies in England and Wales have a
consultation area. Research shows that most pharmacy customers feel that
the level of privacy available for a pharmacy consultation is now
acceptable.
• The pharmacist should always bear the question of privacy in mind and,
where possible, seek to create an atmosphere of confidentiality if sensitive
problems are to be discussed.
• Using professional judgement and personal experience, the pharmacist can
look for signs of hesitancy or embarrassment on the patient’s part and can
suggest moving to a quieter part of the pharmacy or to the consultation
area to continue the conversation.

More Related Content

What's hot

Community Pharmacy Management
Community Pharmacy ManagementCommunity Pharmacy Management
Community Pharmacy Management
Subhash Yende
 
Drug information final
Drug information finalDrug information final
Drug information final
Sitaram Khadka
 
Medication history Interview
Medication history InterviewMedication history Interview
Medication history Interview
Dr. Ramesh Bhandari
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
Venkata subbareddy Bareddy
 
medication adherence
medication adherencemedication adherence
medication adherence
Ramesh Ganpisetti
 
Community pharmacy Infrastructural requirements.pptx
Community pharmacy Infrastructural requirements.pptxCommunity pharmacy Infrastructural requirements.pptx
Community pharmacy Infrastructural requirements.pptx
Ravinandan A P
 
Information services
Information servicesInformation services
Information services
KRUSHNA ZAMBARE
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
KRUSHNA ZAMBARE
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
Sujit Karpe
 
Rational use of otc medication
Rational use of otc medicationRational use of otc medication
Rational use of otc medication
Rafi Bhat
 
PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
Ramesh Ganpisetti
 
over the counter drugs
over the counter drugs over the counter drugs
over the counter drugs
AswathySachidanandan
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
Heena Parveen
 
14ab1t0020 pharmacy and therapeutic committee
14ab1t0020   pharmacy and therapeutic committee14ab1t0020   pharmacy and therapeutic committee
14ab1t0020 pharmacy and therapeutic committee
Ramesh Ganpisetti
 
Drug information center (DIC)
Drug information center (DIC)Drug information center (DIC)
Drug information center (DIC)
Sameh Abdel-ghany
 
Patient Medication History Interview.pptx
Patient Medication History Interview.pptxPatient Medication History Interview.pptx
Patient Medication History Interview.pptx
MangeshBansod2
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
Sohan Patel
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
Dr.Amreen Saba Attariya
 
Hospital Formulary
Hospital FormularyHospital Formulary
Hospital Formulary
sunayanamali
 
Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...
MerrinJoseph1
 

What's hot (20)

Community Pharmacy Management
Community Pharmacy ManagementCommunity Pharmacy Management
Community Pharmacy Management
 
Drug information final
Drug information finalDrug information final
Drug information final
 
Medication history Interview
Medication history InterviewMedication history Interview
Medication history Interview
 
INTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACYINTRODUCTION OF CLINICAL PHARMACY
INTRODUCTION OF CLINICAL PHARMACY
 
medication adherence
medication adherencemedication adherence
medication adherence
 
Community pharmacy Infrastructural requirements.pptx
Community pharmacy Infrastructural requirements.pptxCommunity pharmacy Infrastructural requirements.pptx
Community pharmacy Infrastructural requirements.pptx
 
Information services
Information servicesInformation services
Information services
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
 
Rational use of otc medication
Rational use of otc medicationRational use of otc medication
Rational use of otc medication
 
PHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEEPHARMACY AND THERAPEUTIC COMMITTEE
PHARMACY AND THERAPEUTIC COMMITTEE
 
over the counter drugs
over the counter drugs over the counter drugs
over the counter drugs
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
14ab1t0020 pharmacy and therapeutic committee
14ab1t0020   pharmacy and therapeutic committee14ab1t0020   pharmacy and therapeutic committee
14ab1t0020 pharmacy and therapeutic committee
 
Drug information center (DIC)
Drug information center (DIC)Drug information center (DIC)
Drug information center (DIC)
 
Patient Medication History Interview.pptx
Patient Medication History Interview.pptxPatient Medication History Interview.pptx
Patient Medication History Interview.pptx
 
clinical pharmacy
clinical pharmacyclinical pharmacy
clinical pharmacy
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
 
Hospital Formulary
Hospital FormularyHospital Formulary
Hospital Formulary
 
Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...
 

Similar to OTC drugs - Introduction

Responding to symptos lecture 1
Responding to symptos   lecture 1Responding to symptos   lecture 1
Responding to symptos lecture 1
Siham Gafer
 
Prescription
PrescriptionPrescription
Prescription
SHARIQUE RAZA
 
Diagnostic Error Toolkit
Diagnostic Error ToolkitDiagnostic Error Toolkit
Diagnostic Error Toolkit
EngagingPatients
 
PMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdfPMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdf
MuungoLungwani
 
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdfPMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
MuungoLungwani
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
Prejith Philip Chacko
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
Sreenivasa Reddy Thalla
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
Ramesh Ganpisetti
 
16 ab1t0024
16 ab1t002416 ab1t0024
16 ab1t0024
Ramesh Ganpisetti
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
Khadga Raj
 
AETCOM (Attitude, Ethics and Communication module)
AETCOM (Attitude, Ethics and Communication module)AETCOM (Attitude, Ethics and Communication module)
AETCOM (Attitude, Ethics and Communication module)
Karun Kumar
 
PHARMACIST ROLE IN COMMUNITY PHARMACY , OTC GUIDELINES , PRESCRIPTION PRECAU...
PHARMACIST ROLE IN COMMUNITY PHARMACY ,  OTC GUIDELINES , PRESCRIPTION PRECAU...PHARMACIST ROLE IN COMMUNITY PHARMACY ,  OTC GUIDELINES , PRESCRIPTION PRECAU...
PHARMACIST ROLE IN COMMUNITY PHARMACY , OTC GUIDELINES , PRESCRIPTION PRECAU...
VENKATA RAMA RAO NALLANI
 
How to be your own health advocate
How to be your own health advocateHow to be your own health advocate
How to be your own health advocate
Marie Ennis-O'Connor
 
Medication History Interview.ppt
Medication History Interview.pptMedication History Interview.ppt
Medication History Interview.ppt
Ravinandan A P
 
PATIENTCOUNSELLING in.pptx
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
skShashi1
 
Medication Errors
Medication ErrorsMedication Errors
Medication Errors
ComForCare Home Care
 
Patient counceling arghya
Patient counceling arghyaPatient counceling arghya
Patient counceling arghya
Arghya Chowdhury
 
Medication History Interview.pptx
Medication History Interview.pptxMedication History Interview.pptx
Medication History Interview.pptx
AjithJs2
 
PMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdfPMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdf
MuungoLungwani
 

Similar to OTC drugs - Introduction (20)

Responding to symptos lecture 1
Responding to symptos   lecture 1Responding to symptos   lecture 1
Responding to symptos lecture 1
 
Prescription
PrescriptionPrescription
Prescription
 
Diagnostic Error Toolkit
Diagnostic Error ToolkitDiagnostic Error Toolkit
Diagnostic Error Toolkit
 
PMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdfPMY 6110_1-1-General In - Copy.pdf
PMY 6110_1-1-General In - Copy.pdf
 
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdfPMY 6110_1-1-General Information on Clinical Pharmacy.pdf
PMY 6110_1-1-General Information on Clinical Pharmacy.pdf
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Dispensing medication errors
Dispensing medication errorsDispensing medication errors
Dispensing medication errors
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
16 ab1t0024
16 ab1t002416 ab1t0024
16 ab1t0024
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
 
AETCOM (Attitude, Ethics and Communication module)
AETCOM (Attitude, Ethics and Communication module)AETCOM (Attitude, Ethics and Communication module)
AETCOM (Attitude, Ethics and Communication module)
 
PHARMACIST ROLE IN COMMUNITY PHARMACY , OTC GUIDELINES , PRESCRIPTION PRECAU...
PHARMACIST ROLE IN COMMUNITY PHARMACY ,  OTC GUIDELINES , PRESCRIPTION PRECAU...PHARMACIST ROLE IN COMMUNITY PHARMACY ,  OTC GUIDELINES , PRESCRIPTION PRECAU...
PHARMACIST ROLE IN COMMUNITY PHARMACY , OTC GUIDELINES , PRESCRIPTION PRECAU...
 
How to be your own health advocate
How to be your own health advocateHow to be your own health advocate
How to be your own health advocate
 
Medication History Interview.ppt
Medication History Interview.pptMedication History Interview.ppt
Medication History Interview.ppt
 
PATIENTCOUNSELLING in.pptx
PATIENTCOUNSELLING  in.pptxPATIENTCOUNSELLING  in.pptx
PATIENTCOUNSELLING in.pptx
 
Medication Errors
Medication ErrorsMedication Errors
Medication Errors
 
Patient counceling arghya
Patient counceling arghyaPatient counceling arghya
Patient counceling arghya
 
Medication History Interview.pptx
Medication History Interview.pptxMedication History Interview.pptx
Medication History Interview.pptx
 
PMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdfPMY 6110_1-3-Therapeuti - Copy.pdf
PMY 6110_1-3-Therapeuti - Copy.pdf
 

More from Areej Abu Hanieh

Announcement about my previous presentations - Thank you
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank you
Areej Abu Hanieh
 
Infection - penicillins
Infection - penicillinsInfection - penicillins
Infection - penicillins
Areej Abu Hanieh
 
Hospital acquired pneumonia
Hospital acquired pneumoniaHospital acquired pneumonia
Hospital acquired pneumonia
Areej Abu Hanieh
 
catheter related blood stream infection
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection
Areej Abu Hanieh
 
Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy
Areej Abu Hanieh
 
Cellulitis - Treatment
Cellulitis - TreatmentCellulitis - Treatment
Cellulitis - Treatment
Areej Abu Hanieh
 
Carbapenems - Pharmacology
Carbapenems - PharmacologyCarbapenems - Pharmacology
Carbapenems - Pharmacology
Areej Abu Hanieh
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology
Areej Abu Hanieh
 
Sickle cell anemia
Sickle cell anemia Sickle cell anemia
Sickle cell anemia
Areej Abu Hanieh
 
Poisoning - Treatment
Poisoning - TreatmentPoisoning - Treatment
Poisoning - Treatment
Areej Abu Hanieh
 
Hypertensive urgencies and emergencies
Hypertensive urgencies and emergenciesHypertensive urgencies and emergencies
Hypertensive urgencies and emergencies
Areej Abu Hanieh
 
Diabetic ketoacidosis DKA
Diabetic ketoacidosis DKADiabetic ketoacidosis DKA
Diabetic ketoacidosis DKA
Areej Abu Hanieh
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
Areej Abu Hanieh
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failure
Areej Abu Hanieh
 
Acute Coronary syndrome
Acute Coronary syndrome Acute Coronary syndrome
Acute Coronary syndrome
Areej Abu Hanieh
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
Areej Abu Hanieh
 
Stress ulcer prophylaxis
Stress ulcer prophylaxis Stress ulcer prophylaxis
Stress ulcer prophylaxis
Areej Abu Hanieh
 
Pain in the ICU
Pain in the ICUPain in the ICU
Pain in the ICU
Areej Abu Hanieh
 
Deep Vein Thrombosis - DVT
Deep Vein Thrombosis  - DVTDeep Vein Thrombosis  - DVT
Deep Vein Thrombosis - DVT
Areej Abu Hanieh
 
Anti - Coagulants agents
Anti - Coagulants agentsAnti - Coagulants agents
Anti - Coagulants agents
Areej Abu Hanieh
 

More from Areej Abu Hanieh (20)

Announcement about my previous presentations - Thank you
Announcement about my previous presentations - Thank youAnnouncement about my previous presentations - Thank you
Announcement about my previous presentations - Thank you
 
Infection - penicillins
Infection - penicillinsInfection - penicillins
Infection - penicillins
 
Hospital acquired pneumonia
Hospital acquired pneumoniaHospital acquired pneumonia
Hospital acquired pneumonia
 
catheter related blood stream infection
catheter related blood stream infection catheter related blood stream infection
catheter related blood stream infection
 
Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy Community acquired pneumonia - Pharmacotherapy
Community acquired pneumonia - Pharmacotherapy
 
Cellulitis - Treatment
Cellulitis - TreatmentCellulitis - Treatment
Cellulitis - Treatment
 
Carbapenems - Pharmacology
Carbapenems - PharmacologyCarbapenems - Pharmacology
Carbapenems - Pharmacology
 
Cephalosporins - Pharmacology
Cephalosporins - Pharmacology Cephalosporins - Pharmacology
Cephalosporins - Pharmacology
 
Sickle cell anemia
Sickle cell anemia Sickle cell anemia
Sickle cell anemia
 
Poisoning - Treatment
Poisoning - TreatmentPoisoning - Treatment
Poisoning - Treatment
 
Hypertensive urgencies and emergencies
Hypertensive urgencies and emergenciesHypertensive urgencies and emergencies
Hypertensive urgencies and emergencies
 
Diabetic ketoacidosis DKA
Diabetic ketoacidosis DKADiabetic ketoacidosis DKA
Diabetic ketoacidosis DKA
 
Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency  Asthma and COPD exacerbation - Emergency
Asthma and COPD exacerbation - Emergency
 
Acute decompensated heart failure
Acute decompensated heart failureAcute decompensated heart failure
Acute decompensated heart failure
 
Acute Coronary syndrome
Acute Coronary syndrome Acute Coronary syndrome
Acute Coronary syndrome
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
 
Stress ulcer prophylaxis
Stress ulcer prophylaxis Stress ulcer prophylaxis
Stress ulcer prophylaxis
 
Pain in the ICU
Pain in the ICUPain in the ICU
Pain in the ICU
 
Deep Vein Thrombosis - DVT
Deep Vein Thrombosis  - DVTDeep Vein Thrombosis  - DVT
Deep Vein Thrombosis - DVT
 
Anti - Coagulants agents
Anti - Coagulants agentsAnti - Coagulants agents
Anti - Coagulants agents
 

Recently uploaded

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 

Recently uploaded (20)

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 

OTC drugs - Introduction

  • 1. “Over the Counter” OTC Medications PHAR 437 Abdullah Rabba Ph.D.
  • 2. • OTC drugs are drugs that have been found to be safe and appropriate for use without the supervision of a health care professional such as a physician, and they can be purchased by consumers without a prescription. -FDA
  • 3. • Every working day, people come to the community pharmacy for advice about minor ailments. • With increasing pressure on doctors’ workload it is likely that the community pharmacy will be even more widely used as a first port of call for minor illness.
  • 4. • Members of the public present to pharmacists and their staff in three ways: • Requesting advice about symptoms • Asking to purchase a named medicine • Requiring general health advice (e.g. about dietary supplements)
  • 5. • The pharmacist’s role in responding to symptoms and overseeing the sale of over the counter (OTC) medicines is substantial and requires a mix of knowledge and skills in the area of diseases and their treatment.
  • 6. Key skills • Differentiation between minor and more serious symptoms • Listening skills • Questioning skills • Treatment choices based on evidence of effectiveness • The ability to pass these skills on by acting as a role model for other pharmacy staff
  • 7. ‘patients’ vs ‘customers’ • refer to the people seeking advice about symptoms as patients. • In the past the approach has been to see the pharmacist as expert and the patient as beneficiary of the pharmacist’s information and advice.
  • 8. Patients • They are experts in their own and their children’s health. The patient: • May have experienced the same or a similar condition in the past • May have tried different treatments already • Will have their own ideas about possible causes • Will have views about different sorts of treatments • May have preferences for certain treatment approaches • The pharmacist needs to take this into account in the consultation with the patient and to enable patients to participate by actively eliciting their views and preferences.
  • 9. How to make a consultation more successful from the patient’s perspective – tips from lay people • Introduce yourself with unknown patients • Keep eye contact • Take your time, don’t show your hurry • Avoid prejudice – keep an open mind • Treat patients as human beings and not as a bundle of symptoms • Pay attention to psychosocial issues • Take the patient seriously • Listen – don’t interrupt the patient • Show compassion; be empathic • Be honest without being rude • Avoid jargon, check if the patient understands • Avoid interruptions • Offer sources of trusted further information (leaflets, weblinks)
  • 10. Responding to a request for a named product • You need to ensure that • the requested medicine is appropriate, You also need to bear in mind the • previous knowledge and experience of the purchaser. • Research shows that the majority of patients do not mind being asked questions about their OTC medicine purchase. • exception to this is those who wish to buy a medicine they have used before and would prefer not to be subjected to the same questions each time they ask for the product.
  • 11. • There are two key points here for the pharmacist: • firstly, it can be helpful to briefly explain why questions are needed, and • secondly, fewer questions are normally needed where customers request a named medicine that they have used before. • A suggested sequence • Ask whether the person has used the medicine before, and if the answer is yes, ask if any further information is needed. • Quickly check on whether other medicines are being taken. • If the person has not used the medicine before, more questions will be needed. • It can be useful to ask how the person came to request this particular medicine, for example, have they seen an advertisement for it? Has it been recommended by a friend or family member?
  • 12. Structuring the consultation • W – Who is the patient and what are the symptoms? • H – How long have the symptoms been present? • A – Action taken? • M – Medication being taken?
  • 13. • W: The pharmacist must first establish the identity of the patient: the • person in the pharmacy might be there on someone else’s behalf. • H: Duration of symptoms can be an important indicator of whether referral to the doctor might be required. • In general, the longer the duration, the more likely is the possibility of a serious rather than a minor case. • Most minor conditions are self-limiting and should clear up within a few days.
  • 14. • A: Any action taken by the patient should be established, including the use of any medication to treat the symptoms. • About one in two patients will have tried at least one remedy before seeking the pharmacist’s advice. • If the patient has used one or more apparently appropriate treatments without improvement, referral to the family doctor may be the best course of action.
  • 15. • M: The identity of any medicines taken regularly by the patient is important for two reasons: • possible interactions and • potential adverse reactions. • The pharmacist needs to know about all the medicines being taken by the patient
  • 16. • The community pharmacist has an increasingly important role in detecting adverse drug reactions, and consideration should be given to the possibility that the patient’s symptoms might be an adverse effect caused by medication. • For example, whether • gastric symptoms such as indigestion might be due to a (NSAID) or • a cough might be due to an (ACE) inhibitor being taken by the patient. • Where the pharmacist suspects an adverse drug reaction to a prescribed medicine, the pharmacist should discuss with the doctor what actions should be taken (perhaps including a Yellow Card report to the Commission on Human Medicines (formerly Committee on Safety of Medicines)
  • 17. • The second mnemonic, ASMETHOD, was developed by Derek Balon, a community pharmacist in London: • A – Age and appearance • S – Self or someone else • M – Medication • E – Extra medicines • T – Time persisting • H – History • O – Other symptoms • D – Danger symptoms.
  • 18. • A: Age and appearance • The appearance of the patient can be a useful indicator of whether a minor or more serious condition is involved. • A child who is cheerful and energetic is unlikely to have anything other than a minor problem, whereas one who is quiet and listless, or who is fractious, irritable and feverish, might require referral.
  • 19. • The age of the patient is important because the pharmacist will consider some symptoms as potentially more serious according to age. • For example, acute diarrhoea in an otherwise healthy adult could reasonably be treated by the pharmacist. • However, such symptoms in a baby could produce dehydration more quickly; elderly patients are also at a higher risk of becoming dehydrated. • Oral thrush is common in babies, while less common in older children and adults; the pharmacist’s decision about whether to treat or refer could therefore be influenced by age.
  • 20. • S: Clarification as to who is the patient • M: Medication regularly taken, on prescription or OTC • E: Extra medication tried to treat the current symptoms • T: Time, that is, duration of symptoms
  • 21. • H: History • There are two aspects to the term ‘history’ in relation to responding to symptoms: • first, the history of the symptom being presented, and second, • previous medical history. For example, does the patient have diabetes, hypertension or asthma?
  • 22. • Questioning about the history of a condition may be useful; • How and when the problem began, • how it has progressed and so on. • If the patient has had the problem before, previous episodes should be asked about to determine the action taken by the patient and its degree of success.
  • 23. • O: Other symptoms • Patients generally tend to complain about the symptoms that concern them most. • The pharmacist should always ask whether the patient has noticed any other symptoms or anything different from usual because, for various reasons, patients may not volunteer all the importan information. • Embarrassment may be one such reason, so patients experiencing rectal bleeding may only mention that they have piles or are constipated.
  • 24. • The importance or significance of symptoms may not be recognized by patients, for example, those who have constipation as a side-effect • from a tricyclic antidepressant will probably not mention their dry • mouth because they can see no link or connection between the two problems.
  • 25. • D: Danger symptoms • These are the symptoms or combinations of symptoms that should ring warning bells for pharmacists because immediate referral to the doctor is required. Blood in the sputum, vomit, urine or faeces would be examples of such symptoms, as would unexplained weight loss.
  • 26. • As a general rule, the following indicate a higher risk of a serious condition and should make the pharmacist consider referring the patient to the doctor. • Long duration of symptoms • Recurring or worsening problems • Severe pain • Failed medication (one or more appropriate medicines used already, without improvement) • Suspected adverse drug reactions (to prescription or OTC medicine) • Danger symptoms
  • 27. Injuries • The list below provides general guidance on when a person might need to immediately go to A&E. • There has been a serious head injury with heavy bleeding. • The person is, or has been, unconscious. • There is a suspected broken bone or dislocation. • The person is experiencing severe chest pain or is having trouble breathing. • The person is experiencing severe stomach ache that cannot be treated by OTC remedies. • There is severe bleeding from any part of the body.
  • 28. Privacy in the pharmacy • The vast majority of community pharmacies in England and Wales have a consultation area. Research shows that most pharmacy customers feel that the level of privacy available for a pharmacy consultation is now acceptable. • The pharmacist should always bear the question of privacy in mind and, where possible, seek to create an atmosphere of confidentiality if sensitive problems are to be discussed. • Using professional judgement and personal experience, the pharmacist can look for signs of hesitancy or embarrassment on the patient’s part and can suggest moving to a quieter part of the pharmacy or to the consultation area to continue the conversation.